SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Wake Forest University School of Medicine Develops Digital Platform to Better Care for Stroke Patients
August 9, 2022: Pappas managed Catalyst Fund provides funding to develop Wake Forest University School of Medicine digital platform.